William Lis
2016 - Portola Pharmaceuticals
In 2016, William Lis earned a total compensation of $6.9M as Chief Executive Officer at Portola Pharmaceuticals, a 25% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $185,500 |
|---|---|
| Option Awards | $3,327,192 |
| Salary | $530,000 |
| Stock Awards | $2,834,213 |
| Other | $25,350 |
| Total | $6,902,255 |
Lis received $3.3M in option awards, accounting for 48% of the total pay in 2016.
Lis also received $185.5K in non-equity incentive plan, $530K in salary, $2.8M in stock awards and $25.4K in other compensation.
Rankings
In 2016, William Lis' compensation ranked 967th out of 14,075 executives tracked by ExecPay. In other words, Lis earned more than 93.1% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 967 out of 14,075 | 93rd |
Division Manufacturing | 320 out of 5,489 | 94th |
Major group Chemicals And Allied Products | 83 out of 1,895 | 96th |
Industry group Drugs | 55 out of 1,538 | 96th |
Industry Pharmaceutical Preparations | 47 out of 1,176 | 96th |
Source: SEC filing on April 24, 2017.
Lis' colleagues
We found three more compensation records of executives who worked with William Lis at Portola Pharmaceuticals in 2016.